Quest Launches First Molecular Test To Spot Kidney Organ Transplant Rejection NASDAQ (RTTNews.com) - Quest Diagnostics (DGX) Thursday announced the launch of its Renal Transplant Monitoring laboratory-developed test for identifying renal, or kidney, organ-transplant rejection. According to the company, the Renal Transplant Monitoring ... |
